Association Between Cancer Treatment History and Coronary Inflammation
Main finding · Prevalence of high-FAIResult — go to the resultRelative risk 1.56 95% CI 1.23–1.97Authors' conclusion
In this population, a cancer history, especially in patients with current or recent treatment history, was significantly associated with elevated coronary inflammation.
Study context
- Population
- Patients undergoing coronary CT angiography, 2017–2018
- Participants
- 1,141 patients
- Exposure
- Cancer history vs no cancer history
- Cancern = 188
- Noncancern = 953reference
- Outcome
- High-FAI (perivascular fat attenuation index in the right coronary artery above the 75th percentile)
Main finding
Prevalence of high-FAI
Relative risk
1.56
95% CI 1.23–1.97
Cancervs Noncancer
RR 1.56 (95% CI 1.23–1.97)
As reported in the abstract
Observational data: associations, not effects.
Further findings
| Outcome | RR (95% CI) | |
|---|---|---|
| High-FAI by time after cancer treatment (subgroup)Cancervs Noncancer<5 years postcancer treatment | 1.70 (1.31–2.21) | |
| High-FAI by time after cancer treatment (subgroup)Cancervs Noncancer≥5 years postcancer treatment | 1.29 (0.87–1.92) | |
| 0.512Relative risk (log scale) |
Overall population characteristics
- Median age
- 70 years
- Median fat attenuation index (FAI)
- −75.8 HU
Original publication
Association Between Cancer Treatment History and Coronary Inflammation. JACC Adv. Published 19 November 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →